Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Non-Current Assets (2020 - 2023)

Cullinan Therapeutics has reported Other Non-Current Assets over the past 4 years, most recently at $459000.0 for Q3 2023.

  • Quarterly results put Other Non-Current Assets at $459000.0 for Q3 2023, changed 0.22% from a year ago — trailing twelve months through Sep 2023 was $459000.0 (changed 0.22% YoY), and the annual figure for FY2022 was $459000.0, up 212.24%.
  • Other Non-Current Assets for Q3 2023 was $459000.0 at Cullinan Therapeutics, roughly flat from $459000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for CGEM hit a ceiling of $2.3 million in Q4 2020 and a floor of $100000.0 in Q2 2022.
  • Median Other Non-Current Assets over the past 4 years was $303000.0 (2021), compared with a mean of $452583.3.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 93.61% in 2021 and later soared 359.0% in 2023.
  • Cullinan Therapeutics' Other Non-Current Assets stood at $2.3 million in 2020, then plummeted by 93.61% to $147000.0 in 2021, then skyrocketed by 212.24% to $459000.0 in 2022, then changed by 0.0% to $459000.0 in 2023.
  • The last three reported values for Other Non-Current Assets were $459000.0 (Q3 2023), $459000.0 (Q2 2023), and $459000.0 (Q1 2023) per Business Quant data.